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Hemodialysis patients experience an elevated risk of malnutrition associated with increased
morbidity and mortality. Nocturnal hemodialysis (NHD) results in more effective removal of
waste products and fluids. Therefore, diet and fluid restrictions are less restricted in NHD
patients. However, it is ambiguous whether transition from conventional hemodialysis
(CHD) to NHD leads to improved intake and nutritional status. We studied the effect of NHD
on protein intake, laboratory indices of nutritional status, and body composition.
Study design




Systematic literature search from databases, Medline, Cinahl, EMBASE and The Cochrane
Library, to identify studies reporting on nutritional status post-transition from CHD to NHD.
Intervention
Transition from CHD to NHD.
Outcomes
Albumin, normalized protein catabolic rate (nPCR), dry body weight (DBW), body mass
index (BMI), phase angle, protein intake, and energy intake.
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Results
Systematic literature search revealed 13 studies comprising 282 patients that made the
transition from CHD to NHD. Meta-analysis included nine studies in 229 patients. In control
group controlled studies (n = 4), serum albumin increased significantly from baseline to 4–6
months in NHD patients compared with patients that remained on CHD (mean difference
1.3 g/l, 95% CI 0.02; 2.58, p = 0.05). In baseline controlled studies, from baseline to 4–6
months of NHD treatment, significant increases were ascertained in serum albumin (mean
difference (MD) 1.63 g/l, 95% CI 0.73–2.53, p<0.001); nPCR (MD 0.16 g/kg/day; 95% CI
0.04–0.29, p = 0.01); protein intake (MD 18.9 g, 95% CI 9.7–28.2, p<0.001); and energy
intake (MD 183.2 kcal, 95% CI 16.8–349.7, p = 0.03). Homogeneity was rejected only for
nPCR (baseline versus 4–6 months). DBW, BMI, and phase angle did not significantly
change. Similar results were obtained for comparison between baseline and 8–12 months
of NHD treatment.
Limitations
Most studies had moderate sample sizes; some had incomplete dietary records and rela-
tively brief follow-up period. Studies markedly differed with regard to study design.
Conclusions
NHD is associated with significantly higher protein and energy intake as well as increases
in serum albumin and nPCR. However, the data on body composition are inconclusive.
Introduction
Malnutrition is a frequent problem experienced by hemodialysis patients and forms one of the
primary causes of the high morbidity and mortality in this patient group [1,2]. Various factors
contribute to malnutrition in patients with end-stage renal disease, e.g., increased protein and
energy requirements [3], reduced appetite and food-intake [1,4,5], protein-energy wasting as a
result of chronic inflammation [6,7], and reduced physical activity [8]. Frequent nocturnal
home hemodialysis (NHHD) is the dialysis treatment with the greatest weekly removal of ure-
mic toxins. Nocturnal in-centre hemodialysis (NCHD) is an alternative for patients who are
not applicable for home hemodialysis and have medical and/or social reasons for nocturnal or
more efficient hemodialysis.
According to several studies, prolonged hemodialysis sessions, either at home or in-center,
may improve clinical outcomes [9–11]. A hemodialysis schedule of three times per week of
eight hours improved nutritional status, volume status, and survival rates [12]. Nocturnal
hemodialysis (NHD) combines the long duration dialysis and more frequent treatments which
results in ameliorated elimination of waste products and fluids. Therefore, diet and fluid
restrictions are usually less stringent in NHD patients compared with patients on conventional
hemodialysis (CHD). NHD patients use significantly less or no phosphate binders which may
result in a revitalized appetite [13,14]. Receiving dialysis during the night may also facilitate a
more 'normal' day rhythm with less disturbances of eating patterns. All of these factors may
modify the pattern of food consumption after the transition from CHD to NHD.
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Current knowledge regarding long-term effects of NHD on nutritional status is limited.
Therefore, we performed a systematic review on the effect on nutritional status with the transi-
tion from CHD to NHD. We specifically studied the effect of NHD on protein intake, labora-
tory indices of nutritional status, and body composition.
Methods
Study protocol and information sources
This systematic review was performed between October 3rd, 2013, and February 1st, 2014, from
databases of Medline, Cinahl, EMBASE, and the Cochrane Library, according study protocol
(S1 File). We followed the PRISMA recommendations for reporting data and meta-analysis
(PRISMA 2009) (S1 Table).
Eligibility criteria
Studies were eligible for inclusion if the following criteria were satisfied: (1) nocturnal hemodi-
alysis administered to adults (aged18 years) experiencing chronic kidney disease; (2) out-
comes of interest are scores relating to the patients nutritional status; and (3) full-length
articles published between January 1st, 1990, and February 1st, 2014, and written in English.
Data was required to be obtained by original research and not from reviews. Due to an
expected minimal number of randomized controlled trials (RCT’s), there was no exclusion cri-
terion based upon methodology applied to the studies. The selection procedure included
RCT's, controlled trials, cohort studies including observational studies with a comparison
group, case-control studies, and prospective longitudinal studies comparing nutritional param-
eters prior to and following the transition from CHD to NHD.
Search strategy
Different combinations of terms and ‘strings’ were exploited in order to examine the effects of
the search strategy. The search strategy for Medline is detailed in Table 1.
Study selection and data collection
Two reviewers (SS and AV) separately screened the titles and abstracts of the studies that were
identified through electronic searching in order to select those that were potentially eligible for
inclusion. Additional studies were identified through the references of the pertinent studies.
After the screening, the reviewers discussed any variances in the study selection. Studies were
determined as definitely eligible for inclusion if outcomes were available for laboratory mea-
surements, food intake, or body composition in NHD patients. Study details (publication year,
study design, patients’ characteristics, interventions, and outcomes) were aggregated in a stan-
dard spreadsheet (Microsoft Corporation, Redmond, Washington, USA) for summary and
analyses.
Risk of bias and quality assessment
All full-text versions of potentially relevant studies were independently screened by three
reviewers (SS, AV, KI) to identify whether studies were definitely eligible for inclusion and to
assess their quality. Study quality was assessed by employing the Newcastle-Ottawa Scale for
cohort studies [15]. The scale consists of three quality criteria: selection, comparability, and
outcome. The maximal score is 9 points (4 for selection, 2 for comparability, and 3 for out-
come). Study quality was defined as poor when the score was 1–3, fair when the score was 4–6,
and good when the score was 7–9 points.
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Data extraction
Information was collected of study designs, participant details, exclusion and inclusion criteria,
interventions, and any comparators and outcomes. The following variables were selected after
a pilot search and included as outcome variables: dry body weight, pre-dialysis weight, post-
dialysis weight, dry lean body mass, interdialytic weight gain, fat mass, body mass index (BMI),
body cell mass (BCM), extracellular mass (ECM), extracellular water (ECW), intracellular
water (ICW), energy intake, protein intake, carbohydrate intake, fat intake, albumin levels,
(normalized) protein catabolic rate ((n)PCR), (normalized) protein nitrogen appearance ((n)
PNA), C-Reactive protein (CRP), bioimpedance phase angle, mid upper arm muscle circum-
ference (MUAMC), arm muscle area.
Statistical analyses
To assess differences in nutritional parameters, albumin, nPCR, dry body weight, BMI, phase
angle, protein intake, and energy intake between baseline (on CHD) and, after a certain dura-
tion on NHD, a meta-analysis with a calculation of the mean differences with a 95% confidence
interval was performed utilizing statistical programming language R (R Development Core
Team (2014). There were two types of studies: ‘baseline controlled studies’ in which parameters
at baseline and after a certain period on NHD were compared and ‘control group controlled’
studies that compared patients who made the transition from CHD to NHD with a control-
group of patients that remained on CHD. For meta-analyses, data from baseline controlled and
the NHD-arm of control group controlled studies were pooled whenever possible. To assess
the differences in albumin between the NHD group and the control group, we also performed
Table 1. Search strategy for Medline.
To locate hemodialysis:
1. Renal Dialysis [Mesh:noexp]








To locate Nutritional status
9. Malnutrition [Mesh]
10. Nutritional Physiological Phenomena [Mesh]






17. Body composition [tw]
18. Or/9-17
19. 5 and 8 and 18
doi:10.1371/journal.pone.0157621.t001
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a meta-analysis (other nutritional parameters were assessed in too few control group controlled
studies), with a calculation of the differences in mean with a 95% confidence interval.
Meta-analyses were conducted when the results of this parameter were available in three or
more studies. Studies varied during the intervals wherein nutritional parameters were assessed
after the transition from CHD to NHD. For surveying feasibility, we combined assessments for
4 to 6 months and for 8 to 12 months following the transition. The weights of the meta-analy-
ses were based on the inverse variance method; the heterogeneity parameter (Tau2) for effect
size was based on restricted maximum-likelihood. The random effects model was selected for
the mean difference because an omnipresent treatment effect not being identical in size across
all of the studies was expected [16]. Forest plots were constructed to summarize the outcome of
the meta-analyses.
Characteristics of the NHD patients and the control groups as described in the studies were
reported as mean±SD. One study reported the standard error (SE) as opposed to standard devi-
ation (SD) [14]. The original data were kindly provided to us by the authors and, consecutively,
the SD was calculated from the SE and the number of patients (n) as SD = SE
p
n. One study
had two research groups receiving nocturnal HD; one group dialyzed three times per week,
and the other group dialyzed six times per week [17]. The data of these two research groups
were included separately in the meta-analysis. In the meta-analysis for the comparison of
NHD patients and controls, we primarily included the NHD group that dialyzed six times per
week. In a separate analysis, we also performed the meta-analyses employing the NHD group
that dialyzed three times per week instead of the group that dialyzed six times per week. This
study incorporated two control groups with day-time hemodialysis: one group receiving dialy-
sis three times per week for 2.5 to 4.0 hours and one group having dialysis six times per week
for 1.5 to 2.75 hours. In our analyses, we only used the control group of three times per week
HD because this dialysis schedule was most appropriately comparable with other studies.
Kaysen et al reported the ePCR while the majority of the other studies reported the nPCR
[17]. Upon our request, the authors provided the results of the nPCR [17]. Since one study did
not report the results of (the change in) dry body weight in the text, these results were esti-
mated from the figure [18].
An influence analysis was a component of each meta-analysis to check whether the conclu-
sion critically depends upon the results of a single study. A test for funnel plot asymmetry
based on the linear regression method was added to indicate any risk of bias. Only funnel plots




The literature search yielded a total of 563 articles: 156 in Medline, 300 in EMBASE, 40 in
Cinahl, and 67 in the Cochrane Library. After screening the titles (of these 563 articles) 159
manuscripts and 9 references remained from other sources such as searching citations and
examination of reference lists from relevant studies. After eliminating the duplicates, 89 rec-
ords remained. The abstracts of these articles were screened by 3 reviewers (SS, AV, KI). A
total of 28 full-text articles were assessed for eligibility after which 15 full-text articles were
excluded as they did not meet the inclusion criteria for original research [19–25] or for other
reasons, e.g., the focus on phosphate control [26–29], survival [10,30], dialysis efficiency [31],
and left ventricular mass [32]. Finally, 13 studies were included for this systematic review (Fig
1). Of these, four studies were excluded from meta-analysis for different reasons. In one study,
merely five participants were studied with an observation period of only eight weeks [33], in
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one study, no SD’s were available [34]; in another study, the duration on NHD was not clearly
stated [35]. An additional study was excluded because nocturnal hemodialysis was performed
with online hemodiafiltration [36]. The remaining nine studies incorporated data on one or
more nutritional parameters, and these studies were included in the meta-analysis of the effect
of nocturnal hemodialysis on nutritional status (Fig 1).
Study designs, characteristics, and participants
Table 2 indicates study designs, study characteristics, information on participants, and study
quality. Detailed results of biochemical nutritional parameters, body composition, and food
records are summarized in S2 Table.
Three studies excluded patients that had severe co-morbid conditions (for example, patients
with diabetes mellitus, documented cancer, dementia, cardiac angina during the two week
period prior to the study, active infections) and other relevant conditions such as secondary
hyperparathyroidism with need of calcium-sensitizing therapy, central venous catheter,
required erythrocyte transfusion, severe arterial hypertension, technical reasons, having pace-
makers, or amputation of a major limb [33,37,38]. In another study, an average creatinine and
urea clearance>10 ml/min/1.73m2 were exclusion criteria [17]. In certain studies, short life
expectancy [39], inappropriate housing and inability to speak English [40], lacking the physical
ability or cognitive function to train for NHD [41], as well as the absence of a partner to assist
with in-home NHD [14] were reasons for exclusion. Five studies described no specific exclu-
sion criteria [18,34–36,42]. Major inclusion criteria in all studies were the receptiveness to par-
ticipate and the capability to be trained for NHD.
Inclusively, in all 13 studies, 282 patients made the transition from CHD to NHD. Four of
these 13 studies (comprising 168 patients on NHD) had a control group of CHD patients (208
Fig 1. Selection of articles for the systematic review on nutritional status in NHD patients.
doi:10.1371/journal.pone.0157621.g001
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patients on CHD) [17,37,41,42]. The other nine studies (comprising 114 NHD patients) com-
pared their outcomes to measurements at baseline prior to patients beginning NHD [14,18,33–
36,38–40]. The length of the intervention period on NHD ranged between eight weeks and
three years.
The score on the Newcastle Ottawa Scale for cohort studies ranged from 3 to 8, one study
was considered poor [33], seven were considered fair [14,18,34,35,38–40], and five were con-
sidered good [17,36,37,41,42]. There were no randomized controlled trials.
Biochemical nutritional measurements
Control group controlled studies. Serum albumin was measured in 12 studies. A meta-
analysis comparing NHD patients and control patients that remained on CHD is performed
on the results from four studies. A meta-analysis for the comparison of albumin levels at base-
line (before the transition from CHD to NHD) between NHD patients and CHD patients dem-
onstrated no differences (mean difference -0.1 g/l, 95% CI -0.82; 0.61, P = 0.78) (Fig 2a).
Influence analyses and funnel plot indicated no bias (data not shown). The meta-analysis of
the comparison of the means of three studies that compared NHD patients with a follow up
period of 4–6 months with control patients that continued on CHD for 4–6 months showed a























Alloatti,2002 >6 13 12
(92.3%)
52.0±13.0 In-centre 3 times/week
for 8 hours
prospective Y N N 4
Cravedi,2009 24 7 6
(85.7%)
50.4±11.0 In-centre 3 times/week
for 8 hours
retrospective Y N Y 5
David,2009 12 13 11
(84.6%)
34.8±13.7 In-centre 3 times/week
for 8 hours
prospectivelongitudinal Y N Y 5
Demirci,2013 12 57 41
(71.9%)
47.1±11.7 In-centre 3 times/week
for 8 hours
prospective cohort trial N Y Y 7
Ipema,2012 8 15 11
(73.3%)
53.4±10.3 Home 5/6 times/week
for 8 hours
prospective observational Y N Y 5













week  6 hours
Maduel,2011 12 26 18
(69.2%)
49.2±14.0 In-centre crossover prospective Y N N 8
McPhatter,1999 18 11 5
(45.5%)
50.0±na Home 5–6 times/week
for 4–9 hours
prospectiveobservational Y N N 5
O’Sullivan,
1998
2 5 3 (60%) 46,6±na In-centre 6 times/week
for 8 hours
pilot study Y N N 3
Pierratos,1997 36 11 8
(72.7%)
40±10.0 Home 6–7 times/week
for 8–10 hours
prospective Y N Y 5
Schorr,2011 6 12 6 (50%) 54,2±13.0 Home 5–6 times/week
for 6 hours
randomized trial Y Y Y 7
Sikkes,2009 12 14 13
(92.9%)




Y N Y 5
Spanner,2003 18 13 10
(76.9%)




N Y Y 7
Abbreviations: NHD: nocturnal hemodialysis.
doi:10.1371/journal.pone.0157621.t002
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borderline significant increase in serum albumin in NHD patients (mean difference 1.3 g/l,
95% CI 0.02; 2.58, P = 0.05) (Fig 2b). The influence analysis shows a modification in the results
after removing one particular study (Table 3). The funnel plot indicated no bias (data not
shown). The meta-analysis comparing NHD patients at 12 months following the transition
compared with control patients after 12 months of follow-up also indicated a significant
increase in serum albumin (mean difference 1.57 g/l, 95% CI 0.39; 2.76, P = 0.01) (Fig 2c). The
influence analysis showed a change in the results after omitting a particular study (Table 4).
The funnel plot indicated no bias (data not shown).
Identical results were obtained when the meta-analysis comparing albumin levels between
NHD and CHD control patients was performed with the NHD group that dialyzed three times
Fig 2. Albumin—control group controlled studies. (2a) Forest plot comparing albumin in NHD patients at baseline (before
transition from CHD to NHD) and control CHD patients. (2b) Forest plot comparing albumin in NHD patients after 4–6 months
on NHD and control CHD patients after 4–6 months follow up. (2c) Forest plot comparing albumin in NHD patients after 12
months on NHD and control CHD patients after 12 months follow up.
doi:10.1371/journal.pone.0157621.g002
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per week instead of the NHD group that dialyzed six times per week NHD (S1A, S1B and
S1C Fig).
Baseline controlled studies. The results of eight baseline controlled studies on albumin
are exploited in a meta-analysis. Serum albumin significantly increased from baseline to 4–6
months NHD (mean difference 1.63 g/l, 95% CI 0.73; 2.53, P<0.001) (Fig 3a) and from base-
line to 8–12 months NHD (mean difference 1.79 g/l, 95% CI 1.14; 2.45, P<0.001) (Fig 3b).
Influence analysis and funnel plots indicated no bias (data not shown).
Nine studies reported results on nPCR whereby six could be utilized in the meta-analysis.
As illustrated in Fig 4a, nPCR significantly improved from baseline to 4–6 months on NHD
(mean difference 0.16 g/kg/day, 95% CI 0.04; 0.29, P = 0.01). The homogeneity of effects was
rejected in this meta-analysis by a p-value of 0.005. A test for funnel plot asymmetry revealed
that two studies fell outside the broken lines of the funnel plot in the comparison of nPCR
between baseline and 4–6 months [14,17] (Fig 4c). The influence analysis showed no changes
after the omission of any single study. The nPCR also significantly improved from baseline to
8–12 months NHD (mean difference 0.15 g/kg/day, 95% CI 0.09; 0.22, P<0.001) (Fig 4b). In
this analysis, the homogeneity of the effects was not rejected (P = 0.35). There was neither an
outlying study from the funnel plot nor an influential study after omitting a single study.
CRP was measured in three studies [36–38]. Meta-analysis was not performed since only
two of these studies were appropriate for this analysis. In two studies, CRP did not significantly
differ between baseline and 12 months on NHD [36,38] whereas, in another study, CRP
decreased significantly from baseline to 12 months on NHD [37]. In the latter study, the course
of CRP values did not differ between the NHD group and the control group over the course of
one year [37].
Body composition
All thirteen studies reported data on the course of body weight. Six of these studies could be
employed for the meta-analysis (Fig 5). Dry (post-dialysis) body weight did not change from
baseline to 4–6 months NHD (mean difference 0.28 kg, 95% CI -4.32; 4.88, P = 0.9) (Fig 5a)
and from baseline to 8–12 months NHD (mean difference 1.62 kg, 95% CI -3.70; 6.95,
P = 0.55) (Fig 5b). Influence analyses and funnel plot indicated no bias (data not shown).
Five studies reported data on BMI. As depicted in Fig 6, BMI did not change from baseline
to 4–6 months (mean difference 0.37, 95% CI -1.36; 2.09, P = 0.68) (Fig 6a) and from baseline
Table 3. Influence analysis of albumin at 4–6 months of NHD versus controls on CHD.
Mean difference 95% conﬁdence interval P-value
Omitting Kaysen (6x per week) (2012) 0.77 -1.36–2.91 0.479
Omitting Schorr (2011) 1.59 0.10–3.08 0.037
Omitting Spanner (2003) 1.28 -0.07–2.63 0.063
Pooled estimate 1.30 0.02–2.58 0.046
doi:10.1371/journal.pone.0157621.t003
Table 4. Influence analysis of albumin at 12 months of NHD versus controls CHD.
Mean difference 95% conﬁdence interval P-value
Omitting Demirci (2013) 0.72 -1.11–2.55 0.44
Omitting Kaysen (6x per week) (2012) 1.09 -1.97–4.14 0.486
Omitting Spanner (2003) 1.92 1.01–2.83 0.000
Pooled estimate 1.57 0.39–2.76 0.009
doi:10.1371/journal.pone.0157621.t004
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to 8–12 months (mean difference 0.98, 95% CI -0.99; 2.95, P = 0.33) (Fig 6b). Influence analy-
ses and funnel plot indicated no bias (data not shown).
Lean body mass measured with bioimpedance analysis (BIA) was reported in two studies.
One indicated a significant increase in lean body mass compared with the CHD control group
after 12 months [37]. The other showed no significant change in lean body mass during an
observation period of 12 months [17].
ECW, ICW, ECM, and BCM were measured with BIA in three studies. One study reported
significant decreases in ECW normalized for weight and in ECW normalized for height after
12 months of follow-up compared with the control group [37]. Another study documented
that the ratio of the ECM and BCM (ECM/BCM) decreased significantly from baseline to 12
months on NHD [38]. The third and largest study reported no significant changes in ECW,
ICW, and total body water in NHD patients during 12 months of follow-up [17]. Meta-analysis
was not performed because these studies used different outcome parameters.
Interdialytic weight was reported in two studies. One showed a significant increase from
baseline to 8 months NHD [39] while the other indicated no change between baseline and 12
months of NHD [36].
Three studies measured fat mass. One study denoted a significant increase after 12 months
on NHD compared with the control group [37]. Another study reported no significant change
Fig 3. Albumin—baseline controlled studies. (3a) Forest plot comparing albumin in NHD patients at baseline (before
beginning NHD) and after 4–6 months on NHD. (3b) Forest plot comparing albumin in NHD patients at baseline (before
beginning NHD) and after 8–12 months on NHD.
doi:10.1371/journal.pone.0157621.g003
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Fig 4. normalized Protein Catabolic Rate. (4a) Forest plot comparing nPCR in NHD patients at baseline (prior to beginning NHD)
and after 4–6 months on NHD. (4b) Forest plot comparing nPCR in NHD patients at baseline (prior to beginning NHD) and after 8–12
months on NHD. (4c) Funnel plot comparing nPCR in NHD patients at baseline (prior to beginning NHD) and after 4–6 months on
NHD.
doi:10.1371/journal.pone.0157621.g004
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in the percentage of body fat during one year of NHD [42]. The third study ascertained no
change in fat mass during 12 months on NHD compared with a control group [17]. The use of
a different measurement of fat mass precluded a meta-analysis.
Two studies reported the upper arm muscle area whereby one showed no change in
MUAMC from baseline to 8 months NHD [39]. The other study showed no change in arm
muscle area from baseline to 18 months NHD [42].
Three studies reported phase angle and had divergent outcomes [17,37,38]. As illustrated in
Fig 7, phase angle did not significantly change from baseline to 12 months (mean difference
0.29°, 95% CI -0.004; 0.584, P = 0.05), although there was a positive trend. Influence analysis
and funnel plot indicated no bias (data not shown).
Food records
Protein intake was measured in six studies, of which three could be used for the meta-analysis
[14,39,40]. As shown in Fig 8, protein intake increased significantly from baseline to 4–6
months NHD (mean difference 18.9 g, 95% CI 9.7; 28.2, P<0.001). Influence analysis and fun-
nel plot indicated no bias (data not shown).
Six studies reported energy intake, of which three could be used for meta-analysis
[14,39,40]. As depicted in Fig 9, energy intake increased significantly between baseline and 4–6
months NHD (mean difference 183.2 kcal, 95% CI 16.8; 349.7, P = 0.03). The influence analysis
Fig 5. Dry body weight. (5a) Forest plot comparing dry body weight (DBW) in NHD patients at baseline (prior to beginning NHD)
and after 4–6 months on NHD. (5b) Forest plot comparing dry body weight (DBW) in NHD patients at baseline (prior to beginning
NHD) and after 8–12 months on NHD.
doi:10.1371/journal.pone.0157621.g005
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Fig 6. Bodymass index. (6a) Forest plot comparing body mass index (BMI) in NHD patients at baseline (prior to beginning NHD)
and after 4–6 months on NHD. (6b) Forest plot comparing body mass index (BMI) in NHD patients at baseline (prior to beginning
NHD) and after 8–12 months on NHD.
doi:10.1371/journal.pone.0157621.g006
Fig 7. Forest plot comparing phase angle in NHD patients at baseline (prior to beginning NHD) and
after 12 months on NHD.
doi:10.1371/journal.pone.0157621.g007
Fig 8. Forest plot comparing protein intake in NHD patients at baseline (prior to beginning NHD) and
after 4–6months on NHD.
doi:10.1371/journal.pone.0157621.g008
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showed a change in the results after omitting one particular study (Table 5). The funnel plot
indicated no bias (data not shown). There is a meta-effect, however, the degree of evidence is
not very convincing.
Three studies measured carbohydrate intake and fat intake [14,39,41]. Meta analysis was
not performed since only two of these studies were suitable [14,39]. None of the studies
reported a significant change between baseline and 4 to12 months following the initiation of
NHD [14,39,41].
Discussion
In our meta-analyses, we ascertained that NHD is associated with significantly higher protein
intake, nPCR, and serum albumin compared with CHD. The results for serum albumin are
strengthened by the meta-analysis of studies that prospectively compared patients receiving
NHD and those who remained on CHD, which showed similar positive effects. Energy intake
also increased but with moderate evidence. In contrast, the body composition parameters of
dry body weight, BMI, and phase angle did not change after the initiation of NHD.
There is no ‘gold standard’ for the assessment of nutritional status in hemodialysis patients.
In clinical practice, a combination of parameters is utilized such as the Subjective Global
Assessment, anthropometry (dry body weight, body composition), nPCR, and serum albumin
[43]. This meta-analysis shows that serum albumin levels increased significantly following the
transition from CHD to NHD. Serum albumin is a measure of visceral protein stores and has
prognostic significance in hemodialysis patients [44,45]. Although the increase in serum albu-
min during NHDmay reflect genuine improvement in nutritional status, non-nutritional fac-
tors may contribute to the rise in serum albumin, e.g., improvement of systemic inflammation
and/or reduction of proteinuria as a result of loss of residual renal function. It is unknown
whether the increase in serum albumin after the transition to NHD translates into lower mor-
tality. Notably, serum albumin is also a negative acute phase protein. However, CRP values did
not significantly change post initiation of NHD [36–38]. This suggests that the increase in
serum albumin levels during NHD is related to higher protein intake. This is substantiated by
our meta-analyses demonstrating that both protein intake and nPCR increased significant after
the transition from CHD to NHD. These effects were still evident after 8–12 months of receiv-
ing NHD. In accordance with these findings is the positive meta-effect for energy intake. These
Fig 9. Forest plot comparing energy intake in NHD patients at baseline (prior to beginning NHD) and
after 4–6months on NHD.
doi:10.1371/journal.pone.0157621.g009
Table 5. Influence analysis of energy intake between baseline and after 4–6months of NHD.
Mean difference 95% conﬁdence interval P-value
Omitting Ipema (2012) 218 -56.5–492.6 0.120
Omitting Pierratos (1997) 173 -6.6–351.8 0.059
Omitting Sikkes (2009) 179 -11.3–368.3 0.065
Pooled estimate 183 16.8–349.7 0.031
doi:10.1371/journal.pone.0157621.t005
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findings strongly posit that patients consume more nutrition following the transition to NHD.
Sikkes et al indeed ascertained that 50% of NHD patients had an increased appetite after one
year on NHD and that appetite appeared to improve more in patients with a lower baseline
nPCR [14].
Previous studies showed better survival rates in HD patients with increasing weight and
BMI [46,47] whereas weight loss is most commonly associated with a deterioration of nutri-
tional status [43]. In our meta-analysis, dry body weight and BMI did not significantly vary
during NHD. However, a change in body weight is not a sensitive parameter of nutritional sta-
tus since it is affected by changes in lean body mass and hydration status. Various authors sug-
gested that more frequent and/or longer hemodialysis sessions are associated with better
control of extracellular volume leading to lower blood pressure with less antihypertensive med-
ication [12,48–50]. Therefore, increases in lean body mass during NHDmay be disregarded as
a result of a contemporary reduction in extracellular fluid. Only three studies measured
changes in fluid status during NHD [17,37,38]. Demirci et al indeed reported a significant
decrease in ECW normalized for height and in ECW normalized for weight while both param-
eters increased in the control group of CHD patients [37]. David et al also reported a significant
decrease in ECM/BCM from baseline to 6 months while receiving NHD [38]. In contrast, body
water parameters, including ECW, did not alter during NHD in the study of Kaysen et al [17].
The minimal number of studies and the divergent results preclude a firm conclusion with
regard to a possible substitution of extracellular fluid by lean body mass during NHD.
Lean body mass was measured with BIA in two studies and yielded different outcomes
[17,37]. Kaysen et al determined no differences in lean body mass between the three times per
week NHD group and the six times per week NHD group, although an insignificant decreasing
trend after four months was indicated [17]. The study of Demirci et al showed significant
increases in lean body mass and in fat mass in the NHD patients compared with the CHD con-
trols in the course of one year [37]. Bioimpedance phase angle is a novel technique that may be
exploited as a predictor for impaired muscle function and as an indicator for nutritional status,
health related quality of life, forthcoming hospitalizations, and mortality [51]. Phase angle was
measured in three studies and an insignificant positive trend in NHD patients was found in the
meta-analysis.
In two studies, the upper arm muscle area was measured [39,42]. Spanner et al. discovered a
steady decline in arm muscle area throughout the study period in NHD patients that could be
due to accompanying loss in body weight that was also evident [42]. No change in muscle arm
circumference in NHD patients was found in a study by Ipema et al [39]. The upper arm mus-
cle area can be used for an estimation of the lean body mass and can be a predictor of mortality
in hemodialysis patients [52,53]. On the other hand, it is not a very sensitive measurement
being limited in reproducibility and has a relatively large inter-observer variability [53]. Over-
all, it can be concluded that our analysis does not provide evidence that body composition
changes during NHD.
Remarkably, patients receiving NHD had a significantly higher protein and energy intake
but did not exhibit an increase in BMI or dry body weight. This counter-intuitive finding may
be explained by a negative protein balance induced by the NHD treatment. Various studies
showed that hemodialysis while fasting is associated with a negative protein balance [54–56].
During NHD, patients are asleep and generally do not eat. It is feasible that the significant
increase in protein intake in NHD patients is offset by increased losses of amino acids and
increased hemodialysis-associated catabolism. Alternatively, the failure of patients to increase
physical activity in order to increase fat free mass may play a role in the negative protein bal-
ance. None of the included studies measured daily activity and exercise in NHD patients. Chan
et al studied exercise duration and capacity in patients after conversion to NHD and found an
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improvement [57]. However, in a more recent study, it was found that NHD had no effect on
physical performance, health, and functioning in the NHD group compared with the CHD
group [58].
Although our systematic review and meta-analysis provides new information on the poten-
tial benefits of NHD, the results must be interpreted within the context of methodological limi-
tations. First, most studies were constrained by a minimal sample size, the withdrawal of
patients (on NHD) is not always described, a number of studies had incomplete dietary records
for the participants, and, in several studies, the follow-up duration is relatively brief. Another
limitation is the assumption that the experimental and control groups are independent. In
cases with repeated measurement in the same group of subjects, such an assumption is not
valid. However, meta-analysis programs do not account for the possibility of repeated measure-
ments because these are rarely reported in complete detail. In these cases, however, our
approach based on independence can be expected to underestimate the actual meta-effect.
Considering the fact that there were only thirteen studies considered eligible for this review, we
have decided not to exclude due to study design. This resulted in an extensively varied study
design. Formal blinding of participants is impossible. To anticipate the limitations, several
quality measurements were assessed. In all meta-analysis, we assessed homogeneity of effects,
performed an influence analysis, and tested for funnel plot asymmetry. With a few exceptions,
these tests did not provide evidence for bias. Notably, five out of the 14 meta-analyses were per-
formed with only three studies. In three of these five meta-analyses a deviating influence analy-
sis was found. Two of these were the meta-analyses of ‘control group controlled’ studies
comparing albumin levels at 4–6 and at 12 months on NHD, respectively. The outcomes of
these meta-analysis were used to corroborate the results of ‘baseline controlled studies’ com-
paring baseline with 4–6 and 8–12 months on NHD, respectively. The third meta-analysis with
deviating influence analysis was on energy intake. Although, the three studies in this meta-
analysis showed a uniform pattern, the deviating influence analysis precludes a definite conclu-
sion on the effect of NHD on energy intake. There are no reviews published in regard to nutri-
tional status in nocturnal hemodialysis patients to compare our results with or to be able to
reconsider any type of disagreements in outcomes.
Conclusions and Recommendations
This systematic review illustrates that NHD is associated with a significantly higher protein-
and energy intake and increases in serum albumin and nPCR. Prospective randomized trials
should be conducted to add more evidence to the effect of the transition from CHD to NHD
on nutritional status in its various facets: food intake, laboratory parameters, and body compo-
sition. Additionally, future studies should address the important question whether the higher
protein intake during NHD translates into a lower morbidity and mortality. Finally, more
research should be devoted to the effect of combined treatment with intensive NHD and an
exercise program on body composition.
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